Mayinglong Pharmaceutical Group Co., LTD. (600993.SS)
CNY 25.62
(-0.74%)
CNY 25.62
(-0.74%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 633.25 Million CNY | -10.07% |
| 2022 | 654.65 Million CNY | 11.33% |
| 2021 | 619.5 Million CNY | 38.97% |
| 2020 | 552.17 Million CNY | -0.31% |
| 2019 | 478.18 Million CNY | 18.61% |
| 2018 | 232.2 Million CNY | 8.67% |
| 2017 | 403.5 Million CNY | 9.69% |
| 2016 | 331.93 Million CNY | 15.37% |
| 2015 | 287.89 Million CNY | 10.23% |
| 2014 | 268.14 Million CNY | 1.95% |
| 2013 | 254.6 Million CNY | 21.12% |
| 2012 | 235.14 Million CNY | -4.05% |
| 2011 | 186.43 Million CNY | 18.55% |
| 2010 | 169.85 Million CNY | -28.92% |
| 2009 | 245.48 Million CNY | 153.23% |
| 2008 | 110.86 Million CNY | -51.79% |
| 2007 | 210.57 Million CNY | 84.82% |
| 2006 | 113.55 Million CNY | 24.69% |
| 2005 | 91.06 Million CNY | 19.43% |
| 2004 | 76.24 Million CNY | 22.69% |
| 2003 | 62.14 Million CNY | 43.86% |
| 2002 | 43.2 Million CNY | 9.18% |
| 2001 | 39.56 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 180.09 Million CNY | 5.25% |
| 2024 Q1 | 246.49 Million CNY | 440.19% |
| 2024 Q2 | 152.84 Million CNY | -29.37% |
| 2023 Q4 | 22.06 Million CNY | -86.85% |
| 2023 FY | - CNY | -10.07% |
| 2023 Q1 | 248.85 Million CNY | 121.83% |
| 2023 Q3 | 167.73 Million CNY | 41.23% |
| 2023 Q2 | 118.76 Million CNY | -52.28% |
| 2022 Q4 | 112.18 Million CNY | -32.77% |
| 2022 Q1 | 177.01 Million CNY | 34.49% |
| 2022 Q2 | 174.86 Million CNY | -1.21% |
| 2022 FY | - CNY | 11.33% |
| 2022 Q3 | 166.87 Million CNY | -4.57% |
| 2021 Q1 | 158.75 Million CNY | 486.52% |
| 2021 Q2 | 134.82 Million CNY | -15.07% |
| 2021 Q3 | 143.47 Million CNY | 6.41% |
| 2021 Q4 | 131.61 Million CNY | -8.26% |
| 2021 FY | - CNY | 38.97% |
| 2020 Q4 | 27.06 Million CNY | -77.0% |
| 2020 Q3 | 117.67 Million CNY | -51.71% |
| 2020 FY | - CNY | -0.31% |
| 2020 Q2 | 243.66 Million CNY | 598.51% |
| 2020 Q1 | 34.88 Million CNY | -58.53% |
| 2019 Q1 | 134.34 Million CNY | 91.14% |
| 2019 FY | - CNY | 18.61% |
| 2019 Q2 | 121.71 Million CNY | -9.4% |
| 2019 Q3 | 83.64 Million CNY | -31.27% |
| 2019 Q4 | 84.11 Million CNY | 0.55% |
| 2018 Q4 | 70.28 Million CNY | 38.85% |
| 2018 Q3 | 50.62 Million CNY | -34.02% |
| 2018 Q2 | 76.72 Million CNY | -50.15% |
| 2018 FY | - CNY | 8.67% |
| 2018 Q1 | 153.89 Million CNY | 19.8% |
| 2017 Q1 | 93.73 Million CNY | -3.68% |
| 2017 FY | - CNY | 9.69% |
| 2017 Q3 | 7.6 Million CNY | -93.28% |
| 2017 Q4 | 128.46 Million CNY | 1588.18% |
| 2017 Q2 | 113.25 Million CNY | 20.82% |
| 2016 Q1 | 82.05 Million CNY | 72.65% |
| 2016 FY | - CNY | 15.37% |
| 2016 Q2 | 99.6 Million CNY | 21.38% |
| 2016 Q3 | 40.1 Million CNY | -59.74% |
| 2016 Q4 | 97.3 Million CNY | 142.63% |
| 2015 Q1 | 74.65 Million CNY | 66.66% |
| 2015 FY | - CNY | 10.23% |
| 2015 Q4 | 47.52 Million CNY | -36.43% |
| 2015 Q3 | 74.76 Million CNY | -20.08% |
| 2015 Q2 | 93.54 Million CNY | 25.31% |
| 2014 Q3 | 38.14 Million CNY | -47.02% |
| 2014 Q4 | 44.79 Million CNY | 17.42% |
| 2014 Q2 | 71.99 Million CNY | -16.71% |
| 2014 FY | - CNY | 1.95% |
| 2014 Q1 | 86.44 Million CNY | 79.13% |
| 2013 Q4 | 48.25 Million CNY | 18.72% |
| 2013 Q1 | 79.36 Million CNY | 125.81% |
| 2013 FY | - CNY | 21.12% |
| 2013 Q2 | 68.21 Million CNY | -14.05% |
| 2013 Q3 | 40.65 Million CNY | -40.41% |
| 2012 Q1 | 62.11 Million CNY | 164.03% |
| 2012 Q2 | 76.24 Million CNY | 22.74% |
| 2012 Q4 | 35.14 Million CNY | -33.37% |
| 2012 FY | - CNY | -4.05% |
| 2012 Q3 | 52.75 Million CNY | -30.81% |
| 2011 FY | - CNY | 18.55% |
| 2011 Q3 | 36.01 Million CNY | -52.0% |
| 2011 Q1 | 59.25 Million CNY | 30.28% |
| 2011 Q2 | 75.04 Million CNY | 26.65% |
| 2011 Q4 | 23.52 Million CNY | -34.68% |
| 2010 Q1 | 57.69 Million CNY | -52.01% |
| 2010 Q4 | 45.48 Million CNY | 1227.33% |
| 2010 Q2 | 61.28 Million CNY | 6.22% |
| 2010 FY | - CNY | -28.92% |
| 2010 Q3 | -4.03 Million CNY | -106.58% |
| 2009 Q2 | 122.73 Million CNY | 540.92% |
| 2009 FY | - CNY | 153.23% |
| 2009 Q1 | 19.15 Million CNY | 286.94% |
| 2009 Q4 | 120.22 Million CNY | 228.08% |
| 2009 Q3 | 36.64 Million CNY | -70.14% |
| 2008 Q4 | -10.24 Million CNY | -140.37% |
| 2008 FY | - CNY | -51.79% |
| 2008 Q2 | 28.08 Million CNY | -27.33% |
| 2008 Q1 | 38.64 Million CNY | -72.6% |
| 2008 Q3 | 25.37 Million CNY | -9.65% |
| 2007 FY | - CNY | 84.82% |
| 2007 Q4 | 141.02 Million CNY | 60561.35% |
| 2007 Q3 | -233.23 Thousand CNY | -100.74% |
| 2007 Q2 | 31.4 Million CNY | 57.27% |
| 2007 Q1 | 19.96 Million CNY | -48.93% |
| 2006 Q3 | 21.72 Million CNY | -38.7% |
| 2006 FY | - CNY | 24.69% |
| 2006 Q4 | 39.09 Million CNY | 80.0% |
| 2006 Q1 | 22.12 Million CNY | -25.8% |
| 2006 Q2 | 35.43 Million CNY | 60.12% |
| 2005 Q2 | 27.55 Million CNY | 30.13% |
| 2005 Q3 | 14.98 Million CNY | -45.6% |
| 2005 FY | - CNY | 19.43% |
| 2005 Q4 | 29.82 Million CNY | 98.95% |
| 2005 Q1 | 21.17 Million CNY | 12.19% |
| 2004 FY | - CNY | 22.69% |
| 2004 Q4 | 18.87 Million CNY | 82.23% |
| 2004 Q3 | 10.35 Million CNY | 0.0% |
| 2003 FY | - CNY | 43.86% |
| 2002 FY | - CNY | 9.18% |
| 2001 FY | - CNY | 0.0% |